110.38
Irhythm Holdings Inc stock is traded at $110.38, with a volume of 521.92K.
It is down -0.38% in the last 24 hours and down -10.33% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$110.80
Open:
$110.74
24h Volume:
521.92K
Relative Volume:
0.86
Market Cap:
$3.64B
Revenue:
$787.85M
Net Income/Loss:
$-27.78M
P/E Ratio:
-127.22
EPS:
-0.8676
Net Cash Flow:
$18.75M
1W Performance:
+0.96%
1M Performance:
-10.33%
6M Performance:
-9.37%
1Y Performance:
-35.59%
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Holdings Inc
|
110.38 | 3.64B | 787.85M | -27.78M | 18.75M | -0.8676 |
|
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
iRhythm Holdings, Inc. (IRTC) Stock Price, News, Quote & History - Yahoo! Finance Canada
IRTC5766242 Bond Profile: Coupon and Redemption - TradingView
iRhythm Holdings, Inc. (IRTC) stock price, news, quote and history - Yahoo Finance Australia
Irhythm Technologies Clears Antitrust Hurdle for Vital Connect Acquisition - TipRanks
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now - TradingView
Firing on All Cylinders: iRhythm (NASDAQ:IRTC) Q2 Earnings Lead the Way - Yahoo Finance
IRhythm Holdings, Inc. (IRTC) Investor Outlook: Potential 61% Upside Amid Innovative Cardiac Solutions - DirectorsTalk Interviews
iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Promising 58% Upside for Healthcare Innovators - DirectorsTalk Interviews
iRhythm Holdings Inc (IRTC) Stock Down 5.6% -- Now Undervalued? GF Score: 79/100 - GuruFocus
iRhythm Holdings Market Sentiment - Benzinga España
IRhythm Holdings, Inc. (IRTC): Analyst Ratings Signal A Promising 43% Upside For Investors - DirectorsTalk Interviews
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated? - Yahoo Finance
iRhythm CFO Daniel G. Wilson Sells 773 Shares to Cover RSU Tax Withholding - Kalkine Media
Tax-withholding stock sale by iRhythm (IRTC) CFO - Stock Titan
IRTC Q2 2026 Earnings: Stellar EPS Beat Marks a Major Profitability InflectionBuyback Announcement Report - dars.gov.et
iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 46% Upside Awaits in the Dynamic Cardiac Monitoring Market - DirectorsTalk Interviews
IRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference - Moomoo
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference - manilatimes.net
Is iRhythm Holdings Inc (IRTC) a Bargain After 3.2% Drop? GF Val - GuruFocus
iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds - Yahoo Finance
iRhythm (IRTC) Quarterly Scorecard: The Bottom-Line Figure Beats Its Comparison in Latest Trading; Stock Move: The Stock Loses 1.14% in the Latest SessionEarnings Acceleration Picks - vinanet.vn
iRhythm Holdings, Inc. (IRTC) Investor Outlook: Analyzing a 37% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
iRhythm (IRTC) Shares: Gains 0.42% to Reach $128.52 in the Current Update; Chart Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionUnusual Call Volume - vinanet.vn
iRhythm: The Algorithmic Margin Inflection Changes The Story (NASDAQ:IRTC) - Seeking Alpha
RTW INVESTMENTS, LP Buys iRhythm Holdings Inc (IRTC) -- Shares L - GuruFocus
iRhythm (IRTC) Levels: Gains 2.44% to Reach $127.80 for the Current Session; Level Watch: Price Remains Between $121.41 Support and $134.19 Resistance in the Current UpdateCash Secured Put - siam.in
Q2 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
2 Reasons to Like IRTC (and 1 Not So Much) - Yahoo Finance
iRhythm (IRTC) Quarterly Figures: EPS Beats Its Estimate on the Day; Post-Earnings: Shares Finish 1.44% Down on the DayRevenue Report - vinanet.vn
Why iRhythm Holdings (IRTC) Is Down 6.3% After Raising 2026 Guidance and Cutting LossesAnd What's Next - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
IRTC Maintained by Wells Fargo -- Price Target Lowered to $168 - GuruFocus
Wells Fargo & Company Issues Pessimistic Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Sahm
Citizens Financial Group Inc. RI Buys New Shares in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Stock Price Down 6%Here's Why - MarketBeat
iRhythm Holdings (IRTC) Stock Analysis: A 39.87% Upside Opportunity in the Medical Device Sector - DirectorsTalk Interviews
The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call - Yahoo! Finance Canada
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform - Zacks Investment Research
RTW Investments (IRTC) discloses 6.6% iRhythm stake via 2.18M shares - Stock Titan
Assenagon Asset Management S.A. Sells 248,060 Shares of iRhythm Technologies $IRTC - MarketBeat
Brian Yoor Steps Down from iRhythm Holdings Board; Karen McGinnis Named Audit Committee Chair - Kalkine Media
Artisan Partners group (IRTC) discloses 5.1% iRhythm Holdings position - Stock Titan
IRhythm Holdings, Inc. Announces Board and Committee Changes, Effective August 12, 2026 - marketscreener.com
iRhythm Holdings (IRTC) Edges Lower to $124.47 as Traders Eye Key Resistance at $130.69Ending Diagonal - vinanet.vn
Why iRhythm (IRTC) Shares Are Trading Lower Today - Yahoo Finance
Deals tracker: MaineHealth approved to acquire York Hospital - Modern Healthcare
iRhythm Technologies $IRTC Shares Sold by Bank of America Corp DE - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
iRhythm Holdings CBO/CLO Patrick Michael Murphy Reports Stock Acquisition and Sale in August 2026 - Kalkine Media
iRhythm CEO Quentin Blackford Reports Vesting of Performance RSUs and Subsequent Share Sale for Tax Obligations - kalkinemedia.com
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):